E-LIB Suche - Ergebnisse für: Gralla, Richard J

1

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comp..:

Kennedy, Samantha K. F. ; Goodall, Shannon ; Lee, Shing Fung...
Supportive Care in Cancer. 32 (2024) 5 - p. , 2024

Link: https://doi.org/10.1007/..

2

2023 updated MASCC/ESMO Consensus recommendations: Preventi..:

Scotté, Florian ; Schwartzberg, Lee ; Iihara, Hirotoshi...
Supportive Care in Cancer. 32 (2023) 1 - p. , 2023

Link: https://doi.org/10.1007/..

3

Emetic risk classification and evaluation of the emetogenic..:

Jordan, Karin ; Chan, Alexandre ; Gralla, Richard J....
Supportive Care in Cancer. 32 (2023) 1 - p. , 2023

Link: https://doi.org/10.1007/..

4

Do Patients Regret Having Received Systemic Treatment for A..:

Hollen, Patricia J. ; Gralla, Richard J. ; Gentzler, Ryan D....
The Oncologist. 26 (2020) 3 - p. 224-230 , 2020

Link: https://doi.org/10.1002/..

5

Do we still need to study palonosetron for chemotherapy-ind..:

Chow, Ronald ; Aapro, Matti ; Navari, Rudolph M....
Critical Reviews in Oncology/Hematology. 142 (2019) - p. 164-186 , 2019

Link: https://doi.org/10.1016/..

6

Immune Checkpoint Blockade Is Associated With Durable Respo..:

Sukrithan, Vineeth ; Sandler, Jason ; Gucalp, Rasim..
Clinical Lung Cancer. 20 (2019) 3 - p. e242-e246 , 2019

Link: https://doi.org/10.1016/..

7

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prev..:

Schwartzberg, Lee ; Navari, Rudolph ; Clark-Snow, Rebecca...
The Oncologist. 25 (2019) 3 - p. e589-e597 , 2019

Link: https://doi.org/10.1634/..

8

Content validity and electronic PRO (ePRO) usability of the..:

Gelhorn, Heather L. ; Skalicky, Anne M. ; Balantac, Zaneta...
Supportive Care in Cancer. 26 (2018) 7 - p. 2229-2238 , 2018

Link: https://doi.org/10.1007/..

9

Evaluation of health-related quality of life and symptoms i..:

Reck, Martin ; Brahmer, Julie ; Bennett, Bryan...
European Journal of Cancer. 102 (2018) - p. 23-30 , 2018

Link: https://doi.org/10.1016/..

10

Enhancing evaluation of sarcopenia in patients with non-sma..:

Recio-Boiles, Alejandro ; Galeas, Jose N. ; Goldwasser, Bernard...
Supportive Care in Cancer. 26 (2018) 7 - p. 2353-2359 , 2018

Link: https://doi.org/10.1007/..

11

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Po..:

Lee, Chee Khoon ; Davies, Lucy ; Wu, Yi-Long...
JNCI: Journal of the National Cancer Institute. 109 (2017) 6 - p. , 2017

Link: https://doi.org/10.1093/..

12

Prevention of chemotherapy-induced nausea: the role of neur..:

Bošnjak, Snežana M. ; Gralla, Richard J. ; Schwartzberg, Lee
Supportive Care in Cancer. 25 (2017) 5 - p. 1661-1671 , 2017

Link: https://doi.org/10.1007/..

13

Safety and efficacy of NEPA, an oral fixed combination of n..:

Aapro, Matti ; Jordan, Karin ; Gralla, Richard J....
Journal of Geriatric Oncology. 8 (2017) 1 - p. 56-63 , 2017

Link: https://doi.org/10.1016/..

14

Tolvaptan use in cancer patients with hyponatremia due to t..:

Gralla, Richard J. ; Ahmad, Fatima ; Blais, Jaime D....
Cancer Medicine. 6 (2017) 4 - p. 723-729 , 2017

Link: https://doi.org/10.1002/..

15

Erratum to: 2016 updated MASCC/ESMO consensus recommendatio..:

Roila, Fausto ; Warr, David ; Hesketh, Paul J....
Supportive Care in Cancer. 25 (2016) 1 - p. 295-296 , 2016

Link: https://doi.org/10.1007/..